About
Dr. Matt Kaeberlein is the Chief Executive Officer at Optispan, Inc., Affiliate Professor…
Activity
-
Brand-new interview with Mike Mutzel, MS up on the podcast today! Matt Kaeberlein and Mike chat: - vitamin D supplementation - heavy metals and…
Brand-new interview with Mike Mutzel, MS up on the podcast today! Matt Kaeberlein and Mike chat: - vitamin D supplementation - heavy metals and…
Liked by Matt Kaeberlein
-
great slide by the great Brian Kennedy, pillar :) of the geroscience field we will most likely not get much further than slowing aging if we stick…
great slide by the great Brian Kennedy, pillar :) of the geroscience field we will most likely not get much further than slowing aging if we stick…
Liked by Matt Kaeberlein
Experience
Education
Volunteer Experience
-
Senior Editor
eLife Sciences Publications, Ltd.
- 1 year 4 months
Science and Technology
Senior Editor at eLife
-
President
AMERICAN AGING ASSOCIATION INC
- 1 year 1 month
Science and Technology
President of the American Aging Association in charge of organizing and running the 2016 Annual Meeting.
-
Editorial Board
npg Aging and Mechanisms of Disease
- Present 10 years
Science and Technology
-
Honorary Advisory Board
Oncotarget
- Present 10 years
Science and Technology
-
Editorial Board
BioEssays
- Present 10 years
Science and Technology
-
External Advisory Board, JAX Aging Center
The Jackson Laboratory
- Present 12 years
Science and Technology
-
Interventions Testing Program Steering Committee
National Institute on Aging (NIA)
- Present 13 years
Science and Technology
-
Editorial Board
Frontiers in Genetics of Aging
- Present 13 years
Science and Technology
-
Editorial Board
BMC Longevity and Healthspan
- 3 years
Science and Technology
-
Editorial Board
Aging Cell
- 6 years
Science and Technology
-
Section Editor
Current Genomics
- 4 years
Science and Technology
-
Associate Editor
Cell Cycle
- Present 15 years
Science and Technology
-
Developer and Curator, Aging Genes and Interventions Database, SAGE KE
AAAS
- 4 years
Science and Technology
-
Board of Reviewing Editors
eLife Sciences Publications, Ltd.
- 2 years 9 months
Science and Technology
Publications
-
Deficiency of the RNA-binding protein Cth2 extends yeast replicative lifespan by alleviating its repressive effects on mitochondrial function
Cell Reports 40(3):111113
Iron dyshomeostasis contributes to aging, but little information is available about the molecular mechanisms. Here, we provide evidence that in Saccharomyces cerevisiae, aging is associated with altered expression of genes involved in iron homeostasis. We further demonstrate that defects in the conserved mRNA-binding protein Cth2, which controls stability and translation of mRNAs encoding iron-containing proteins, increase lifespan by alleviating its repressive effects on mitochondrial…
Iron dyshomeostasis contributes to aging, but little information is available about the molecular mechanisms. Here, we provide evidence that in Saccharomyces cerevisiae, aging is associated with altered expression of genes involved in iron homeostasis. We further demonstrate that defects in the conserved mRNA-binding protein Cth2, which controls stability and translation of mRNAs encoding iron-containing proteins, increase lifespan by alleviating its repressive effects on mitochondrial function. Mutation of the conserved cysteine residue in Cth2 that inhibits its RNA-binding activity is sufficient to confer longevity, whereas Cth2 gain of function shortens replicative lifespan. Consistent with its function in RNA degradation, Cth2 deficiency relieves Cth2-mediated post-transcriptional repression of nuclear-encoded components of the electron transport chain. Our findings uncover a major role of the RNA-binding protein Cth2 in the regulation of lifespan and suggest that modulation of iron starvation signaling can serve as a target for potential aging interventions.
-
Evidence that conserved essential genes are enriched for pro-longevity factors
Geroscience
At the cellular level, many aspects of aging are conserved across species. This has been demonstrated by numerous studies in simple model organisms like Saccharomyces cerevisiae, Caenorhabdits elegans, and Drosophila melanogaster. Because most genetic screens examine loss of function mutations or decreased expression of genes through reverse genetics, essential genes have often been overlooked as potential modulators of the aging process. By taking the approach of increasing the expression…
At the cellular level, many aspects of aging are conserved across species. This has been demonstrated by numerous studies in simple model organisms like Saccharomyces cerevisiae, Caenorhabdits elegans, and Drosophila melanogaster. Because most genetic screens examine loss of function mutations or decreased expression of genes through reverse genetics, essential genes have often been overlooked as potential modulators of the aging process. By taking the approach of increasing the expression level of a subset of conserved essential genes, we found that 21% of these genes resulted in increased replicative lifespan in S. cerevisiae. This is greater than the ~ 3.5% of genes found to affect lifespan upon deletion, suggesting that activation of essential genes may have a relatively disproportionate effect on increasing lifespan. The results of our experiments demonstrate that essential gene overexpression is a rich, relatively unexplored means of increasing eukaryotic lifespan.
-
Once-daily feeding is associated with better health in companion dogs: results from the Dog Aging Project
Geroscience 44(3):1779-1790.
A variety of diets have been studied for possible anti-aging effects. In particular, studies of intermittent fasting and time-restricted feeding in laboratory rodents have found evidence of beneficial health outcomes. Companion dogs represent a unique opportunity to study diet in a large mammal that shares human environments. The Dog Aging Project has been collecting data on thousands of companion dogs of all different ages, sizes, and breeds since 2019. We leveraged this diverse…
A variety of diets have been studied for possible anti-aging effects. In particular, studies of intermittent fasting and time-restricted feeding in laboratory rodents have found evidence of beneficial health outcomes. Companion dogs represent a unique opportunity to study diet in a large mammal that shares human environments. The Dog Aging Project has been collecting data on thousands of companion dogs of all different ages, sizes, and breeds since 2019. We leveraged this diverse cross-sectional dataset to investigate associations between feeding frequency and cognitive function (n = 10,474) as well as nine broad categories of health conditions (n = 24,238). Controlling for sex, age, breed, and other potential confounders, we found that dogs fed once daily rather than more frequently had lower mean scores on a cognitive dysfunction scale, and lower odds of having gastrointestinal, dental, orthopedic, kidney/urinary, and liver/pancreas disorders. Therefore, we find that once-daily feeding is associated with better health in multiple domains. Future research with longitudinal data can provide stronger evidence for a possible causal effect of feeding frequency on health in companion dogs.
-
Once-daily feeding is associated with better health in companion dogs: results from the Dog Aging Project
Geroscience 44(3):1779-1790.
A variety of diets have been studied for possible anti-aging effects. In particular, studies of intermittent fasting and time-restricted feeding in laboratory rodents have found evidence of beneficial health outcomes. Companion dogs represent a unique opportunity to study diet in a large mammal that shares human environments. The Dog Aging Project has been collecting data on thousands of companion dogs of all different ages, sizes, and breeds since 2019. We leveraged this diverse…
A variety of diets have been studied for possible anti-aging effects. In particular, studies of intermittent fasting and time-restricted feeding in laboratory rodents have found evidence of beneficial health outcomes. Companion dogs represent a unique opportunity to study diet in a large mammal that shares human environments. The Dog Aging Project has been collecting data on thousands of companion dogs of all different ages, sizes, and breeds since 2019. We leveraged this diverse cross-sectional dataset to investigate associations between feeding frequency and cognitive function (n = 10,474) as well as nine broad categories of health conditions (n = 24,238). Controlling for sex, age, breed, and other potential confounders, we found that dogs fed once daily rather than more frequently had lower mean scores on a cognitive dysfunction scale, and lower odds of having gastrointestinal, dental, orthopedic, kidney/urinary, and liver/pancreas disorders. Therefore, we find that once-daily feeding is associated with better health in multiple domains. Future research with longitudinal data can provide stronger evidence for a possible causal effect of feeding frequency on health in companion dogs.
-
An open science study of ageing in companion dogs.
Nature 602(7895):51-57
The Dog Aging Project is a long-term longitudinal study of ageing in tens of thousands of companion dogs. The domestic dog is among the most variable mammal species in terms of morphology, behaviour, risk of age-related disease and life expectancy. Given that dogs share the human environment and have a sophisticated healthcare system but are much shorter-lived than people, they offer a unique opportunity to identify the genetic, environmental and lifestyle factors associated with healthy…
The Dog Aging Project is a long-term longitudinal study of ageing in tens of thousands of companion dogs. The domestic dog is among the most variable mammal species in terms of morphology, behaviour, risk of age-related disease and life expectancy. Given that dogs share the human environment and have a sophisticated healthcare system but are much shorter-lived than people, they offer a unique opportunity to identify the genetic, environmental and lifestyle factors associated with healthy lifespan. To take advantage of this opportunity, the Dog Aging Project will collect extensive survey data, environmental information, electronic veterinary medical records, genome-wide sequence information, clinicopathology and molecular phenotypes derived from blood cells, plasma and faecal samples. Here, we describe the specific goals and design of the Dog Aging Project and discuss the potential for this open-data, community science study to greatly enhance understanding of ageing in a genetically variable, socially relevant species living in a complex environment.
Other authorsSee publication -
Antiaging diets: Separating fact from fiction
Science 374(6570):eabe7365
Caloric restriction has been known for nearly a century to extend life span and delay age-associated pathology in laboratory animals. More recently, alternative “antiaging” diet modalities have been described that provide new mechanistic insights and potential clinical applications. These include intermittent fasting, fasting-mimicking diets, ketogenic diets, time-restricted feeding, protein restriction, and dietary restriction of specific amino acids. Despite mainstream popularization of some…
Caloric restriction has been known for nearly a century to extend life span and delay age-associated pathology in laboratory animals. More recently, alternative “antiaging” diet modalities have been described that provide new mechanistic insights and potential clinical applications. These include intermittent fasting, fasting-mimicking diets, ketogenic diets, time-restricted feeding, protein restriction, and dietary restriction of specific amino acids. Despite mainstream popularization of some of these diets, many questions remain about their efficacy outside of a laboratory setting. Studies of these interventions support at least partially overlapping mechanisms of action and provide insights into what appear to be highly conserved mechanisms of biological aging.
Other authorsSee publication -
Evolution of natural lifespan variation and molecular strategies of extended lifespan in yeaste
eLife 10:e64860
To understand the genetic basis and selective forces acting on longevity, it is useful to examine lifespan variation among closely related species, or ecologically diverse isolates of the same species, within a controlled environment. In particular, this approach may lead to understanding mechanisms underlying natural variation in lifespan. Here, we analyzed 76 ecologically diverse wild yeast isolates and discovered a wide diversity of replicative lifespan (RLS). Phylogenetic analyses pointed…
To understand the genetic basis and selective forces acting on longevity, it is useful to examine lifespan variation among closely related species, or ecologically diverse isolates of the same species, within a controlled environment. In particular, this approach may lead to understanding mechanisms underlying natural variation in lifespan. Here, we analyzed 76 ecologically diverse wild yeast isolates and discovered a wide diversity of replicative lifespan (RLS). Phylogenetic analyses pointed to genes and environmental factors that strongly interact to modulate the observed aging patterns. We then identified genetic networks causally associated with natural variation in RLS across wild yeast isolates, as well as genes, metabolites, and pathways, many of which have never been associated with yeast lifespan in laboratory settings. In addition, a combined analysis of lifespan-associated metabolic and transcriptomic changes revealed unique adaptations to interconnected amino acid biosynthesis, glutamate metabolism, and mitochondrial function in long-lived strains. Overall, our multiomic and lifespan analyses across diverse isolates of the same species shows how gene-environment interactions shape cellular processes involved in phenotypic variation such as lifespan.
-
Evidence that C/EBP-β LAP Increases Fat Metabolism and Protects Against Diet-Induced Obesity in Response to mTOR Inhibition
Frontiers in Aging 2:738512
Aging and obesity are common risk factors for numerous chronic pathologies, and the compounding effects of old age and increased adiposity pose a serious threat to public health. Starting from the assumption that aging and obesity may have shared underpinnings, we investigated the antiobesogenic potential of a successful longevity intervention, the mTORC1 inhibitor rapamycin. We find that rapamycin prevents diet-induced obesity in mice and increases the activity of C/EBP-β LAP, a transcription…
Aging and obesity are common risk factors for numerous chronic pathologies, and the compounding effects of old age and increased adiposity pose a serious threat to public health. Starting from the assumption that aging and obesity may have shared underpinnings, we investigated the antiobesogenic potential of a successful longevity intervention, the mTORC1 inhibitor rapamycin. We find that rapamycin prevents diet-induced obesity in mice and increases the activity of C/EBP-β LAP, a transcription factor that regulates the metabolic shift to lipid catabolism observed in response to calorie restriction. Independent activation of C/EBP-β LAP with the antiretroviral drug adefovir dipivoxil recapitulates the anti-obesogenic effects of rapamycin without reducing signaling through mTORC1 and increases markers of fat catabolism in the liver. Our findings support a model that C/EBP-β LAP acts downstream of mTORC1 signaling to regulate fat metabolism and identifies a novel drug that may be exploited to treat obesity and decrease the incidence of age-related disease.
Other authorsSee publication -
Generation and characterization of a tractable C. elegans model of tauopathy
Geroscience 43(5):2621-2631
Alzheimer's disease(AD) is an age-associated neurodegenerative disease that results in deterioration of memory and cognitive function. As a currently untreatable disorder, AD has emerged as one of the defining biomedical challenges of our time. Thus, new approaches that can examine the cellular and molecular mechanisms underlying age-related AD pathology are sorely needed. One of the hallmarks of Alzheimer's disease is the hyperphosphorylation of the tau protein. Caenorhabditis elegans have…
Alzheimer's disease(AD) is an age-associated neurodegenerative disease that results in deterioration of memory and cognitive function. As a currently untreatable disorder, AD has emerged as one of the defining biomedical challenges of our time. Thus, new approaches that can examine the cellular and molecular mechanisms underlying age-related AD pathology are sorely needed. One of the hallmarks of Alzheimer's disease is the hyperphosphorylation of the tau protein. Caenorhabditis elegans have been previously used to study the genetic pathways impacted by tau proteotoxic stress; however, currently, available C. elegans tau models express the human protein solely in neurons, which are unresponsive to global RNA interference (RNAi). This limits powerful RNAi screening methods from being utilized effectively in these disease models. Our goal was to develop a C. elegans tau model that has pronounced tau-induced disease phenotypes in cells that can be modified by feeding RNAi methods. Towards this end, we generated a novel C. elegans transgenic line with codon-optimized human 0N4R V337M tau expressed in the body wall muscle under the myo-3 promoter. Immunoblotting experiments revealed that the expressed tau is phosphorylated on epitopes canonically associated with human AD pathology. The tau line has significantly reduced health metrics, including egg laying, growth rate, paralysis, thrashing frequency, crawling speed, and lifespan. These defects are suppressed by RNAi directed against the tau mRNA. Taken together, our results suggest that this alternative tau genetic model could be a useful tool for uncovering the mechanisms that influence the hyperphosphorylation and toxicity of human tau via RNAi screening and other approaches.
-
A prion accelerates proliferation at the expense of lifespan
eLife 10:e60917
In fluctuating environments, switching between different growth strategies, such as those affecting cell size and proliferation, can be advantageous to an organism. Trade-offs arise, however. Mechanisms that aberrantly increase cell size or proliferation-such as mutations or chemicals that interfere with growth regulatory pathways-can also shorten lifespan. Here we report a natural example of how the interplay between growth and lifespan can be epigenetically controlled. We find that a highly…
In fluctuating environments, switching between different growth strategies, such as those affecting cell size and proliferation, can be advantageous to an organism. Trade-offs arise, however. Mechanisms that aberrantly increase cell size or proliferation-such as mutations or chemicals that interfere with growth regulatory pathways-can also shorten lifespan. Here we report a natural example of how the interplay between growth and lifespan can be epigenetically controlled. We find that a highly conserved RNA-modifying enzyme, the pseudouridine synthase Pus4/TruB, can act as a prion, endowing yeast with greater proliferation rates at the cost of a shortened lifespan. Cells harboring the prion grow larger and exhibit altered protein synthesis. This epigenetic state, [BIG+] (better in growth), allows cells to heritably yet reversibly alter their translational program, leading to the differential synthesis of dozens of proteins, including many that regulate proliferation and aging. Our data reveal a new role for prion-based control of an RNA-modifying enzyme in driving heritable epigenetic states that transform cell growth and survival.
-
Canine Cognitive Dysfunction (CCD) scores correlate with amyloid beta 42 levels in dog brain tissue
Geroscience 43(5):2379-2386
Alzheimer's disease (AD) is a significant burden for human health that is increasing in prevalence as the global population ages. There is growing recognition that current preclinical models of AD are insufficient to recapitulate key aspects of the disease. Laboratory models for AD include mice, which do not naturally develop AD-like pathology during aging, and laboratory Beagle dogs, which do not share the human environment. In contrast, the companion dog shares the human environment and…
Alzheimer's disease (AD) is a significant burden for human health that is increasing in prevalence as the global population ages. There is growing recognition that current preclinical models of AD are insufficient to recapitulate key aspects of the disease. Laboratory models for AD include mice, which do not naturally develop AD-like pathology during aging, and laboratory Beagle dogs, which do not share the human environment. In contrast, the companion dog shares the human environment and presents a genetically heterogeneous population of animals that might spontaneously develop age-associated AD-like pathology and cognitive dysfunction. Here, we quantitatively measured amyloid beta (Aβ42 or Abeta-42) levels in three areas of the companion dog brain (prefrontal cortex, temporal cortex, hippocampus/entorhinal cortex) and cerebrospinal fluid (CSF) using a newly developed Luminex assay. We found significant positive correlations between Aβ42 and age in all three brain regions. Brain Aβ42 abundance in all three brain regions was also correlated with Canine Cognitive Dysfunction Scale score in a multivariate analysis. This latter effect remained significant when correcting for age, except in the temporal cortex. There was no correlation between Aβ42 in CSF and cognitive scores; however, we found a significant positive correlation between Aβ42 in CSF and body weight, as well as a significant negative correlation between Aβ42 in CSF and age. Our results support the suitability of the companion dog as a model for AD and illustrate the utility of veterinary biobanking to make biospecimens available to researchers for analysis.
Other authorsSee publication -
Modulating mTOR in aging and health.
Aging and Health - A Systems Biology Perspective
-
Rapamycin and ageing: when, for how long, and how much?
Journal of Genetics and Genomics
-
Replicative life span analysis in budding yeast.
Methods in Molecular Biology
-
Preserving youth: does rapamycin deliver?
Science Translational Medicine
Honors & Awards
-
Robert W. Kleemeier Award
Gerontological Society of America
The Robert W. Kleemeier Award is given annually to a member of The Gerontological Society of America in recognition for outstanding research in the field of gerontology.
-
Nathan W. Shock Award
National Institute on Aging
-
Pioneer Award
Frontiers in Alzheimer's and Aging Research
-
Parkin Award and Lecture
Iowa Neuroscience Institute
-
Next Generation Medicine Award and Lecture
University of Washington
-
Fellow, American Association for the Advancement of Science
American Association for the Advancement of Science
-
Fellow, American Aging Association
American Aging Association
-
Nelson Fausto Distinguished Mentor Award
Department of Pathology, University of Washington
-
M.J. Murdock Charitable Trust Award
M.J. Murdock Charitable Trust
-
Fellow, Gerontological Society of America
Gerontological Society of America
-
Vincent Cristofalo Rising Star in Aging Research Award
American Federation for Aging Research
-
Undergraduate Research Mentor of the Year
University of Washington
-
Young Investigator Science in Medicine Lecture
University of Washington
-
Alzheimer’s Association New Investigator Award
Alzheimer's Association
-
New Scholar in Aging Award
Ellison Medical Foundation
-
Breakthroughs in Gerontology Award
Glenn Foundation
-
Junior Faculty Research Award
American Federation for Aging Research
-
Genetic Approaches to Aging Postdoctoral Fellowship
National Institute on Aging
-
Chang Biochemistry Award
Western Washington University Chemistry Department
-
Outstanding Graduate
Western Washington University Chemistry Department
Organizations
-
Federation of American Societies for Experimental Biology
Director
- PresentFASEB's mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy. FASEB represents 30 scientific societies and over 125,000 researchers worldwide. http://www.faseb.org/home.aspx
-
Dog Aging Project
Director
- PresentThe Dog Aging Project is a unique opportunity to advance scientific discovery while simultaneously providing enormous benefit for people and their pets. Our goal is to increase the healthy longevity of companion dogs by bringing cutting edge research on the basic mechanisms of aging to veterinary clinical medicine. www.dogagingproject.com
-
University of Washington Healthy Aging and Longevity Research Institute
Director
- PresentAs a world-wide leader in aging research, the University of Washington has launched the Healthy Aging and Longevity Research Institute, otherwise known as HALo, to support new research initiatives and encourage multi-disciplinary collaboration by aging researchers throughout the University. HALo aims to promote not just a long life, but lifelong well-being; healthspan, rather than lifespan. Our goal is to understand the biology of aging and what causes an organism to switch from youthful…
As a world-wide leader in aging research, the University of Washington has launched the Healthy Aging and Longevity Research Institute, otherwise known as HALo, to support new research initiatives and encourage multi-disciplinary collaboration by aging researchers throughout the University. HALo aims to promote not just a long life, but lifelong well-being; healthspan, rather than lifespan. Our goal is to understand the biology of aging and what causes an organism to switch from youthful and healthy to aged and infirm. More importantly, we want to use this understanding to extend healthspan—the length of life spent free from severe age-related disease. This paradigm-shifting approach, to focus on slowing the aging process and extending healthspan, could immediately add another decade or two of healthy, productive life for most people. www.uwhealthyaging.org
-
American Aging Association
President, President Elect, Board of Directors, Executive Committee, Member
- PresentThe American Aging Association is a group of experts dedicated to understanding the basic mechanisms of aging and the development of interventions in age-related disease to increase healthy lifespan for all. It is the only scientific organization in the United States solely devoted to advancing research on the basic biology of aging. http://www.americanagingassociation.org/
More activity by Matt
-
this project literally takes the potential of rapamycin (and gerotherapeutics) to the next level we want to accelerate progress in the field -- we…
this project literally takes the potential of rapamycin (and gerotherapeutics) to the next level we want to accelerate progress in the field -- we…
Liked by Matt Kaeberlein
-
I had mixed feelings about recording this and still do to some extent, but I think it's important to try to provide an honest appraisal of the…
I had mixed feelings about recording this and still do to some extent, but I think it's important to try to provide an honest appraisal of the…
Shared by Matt Kaeberlein
-
The latest update to the #millionmoleculechallenge open access database is live! https://lnkd.in/gFpAeUuW The hunt is on for lifespan extending…
The latest update to the #millionmoleculechallenge open access database is live! https://lnkd.in/gFpAeUuW The hunt is on for lifespan extending…
Liked by Matt Kaeberlein
-
"That's the beauty of making claims around anti aging, or longevity, "escape velocity": nobody can prove you wrong. If you ARE wrong, you're going to…
"That's the beauty of making claims around anti aging, or longevity, "escape velocity": nobody can prove you wrong. If you ARE wrong, you're going to…
Liked by Matt Kaeberlein
-
We at Ora Biomedical, Inc. are committed to growing the broadest and most diverse uses for longevity technologies.
We at Ora Biomedical, Inc. are committed to growing the broadest and most diverse uses for longevity technologies.
Liked by Matt Kaeberlein
-
not sure where the archnemesis or no-hold schtick came from but the conversation with Matt Kaeberlein was very good
not sure where the archnemesis or no-hold schtick came from but the conversation with Matt Kaeberlein was very good
Liked by Matt Kaeberlein
-
"NR is valuable garbage." "I'm not a doubter of the geroscience hypothesis—I just don't know to what degree it's actionable for people right…
"NR is valuable garbage." "I'm not a doubter of the geroscience hypothesis—I just don't know to what degree it's actionable for people right…
Liked by Matt Kaeberlein
-
Fascinating longevity chat between Linus Petersson and Matt Kaeberlein. mTOR inhibitors, dogs, high-throughput drug discovery and…
Fascinating longevity chat between Linus Petersson and Matt Kaeberlein. mTOR inhibitors, dogs, high-throughput drug discovery and…
Liked by Matt Kaeberlein
-
Anyone who cares about longevity science should read the The Alliance for Longevity Initiatives proposal "A New National Institute for Longevity and…
Anyone who cares about longevity science should read the The Alliance for Longevity Initiatives proposal "A New National Institute for Longevity and…
Shared by Matt Kaeberlein
-
In response to the recent NIH reform proposal from the Energy and Commerce Committee, which recommends merging the NIA into a dementia-focused…
In response to the recent NIH reform proposal from the Energy and Commerce Committee, which recommends merging the NIA into a dementia-focused…
Liked by Matt Kaeberlein
-
Guess who funds all the dream come true science (Impetus Grants). Congrats to Zev Williams & Yousin Suh who are making the VIBRANT trial…
Guess who funds all the dream come true science (Impetus Grants). Congrats to Zev Williams & Yousin Suh who are making the VIBRANT trial…
Liked by Matt Kaeberlein
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More